Thanks Alby for the update. Quote: Mylan has world wide marketing rights for TPM/ Daptomycin. Seeing we have taken these guys to arbitration, does anyone know, Is that evaluation worth the paper it was written on?
Ann: Phosphagenics Arbitration Award Issued, page-255
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add POH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.0¢ |
Change
0.000(0.00%) |
Mkt cap ! n/a | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| POH (ASX) Chart |
Day chart unavailable
